Goldman Sachs is a market leader, and the biggest component of the Dow Jones Industrial Average. See why I rate GS stock a ...

It’s been tough for Wall Street strategists to hold their nerve in the face of the ever-changing tariff policy.

Goldman Sachs plans to trim its staffing by 3% to 5% in an annual performance review process this spring, said a source ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

The most recent trading session ended with Goldman Sachs (GS) standing at $559.67, reflecting a -1.41% shift from the previouse trading day's closing. The stock fell short of the S&P 500, which ...

Technology is the second worst-performing S&P 500 sector year-to-date with about an 8 per cent loss, after consumer ...

The U.S. stock market’s sell-off cut deeper on Monday as Wall Street questioned how much pain President Donald Trump will let ...

Between them, Novo Nordisk and Eli Lilly dominate a weight-loss market that Goldman Sachs analysts reportedly said could ...